A Phase I Study of PLX038 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Tumors
Related studies linked through entity extraction aliases.
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of E7046 in Subjects With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE4
A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Atezolizumab in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Perioperative Risk Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
- Status
- UNKNOWN
- Phase
- PHASE1
Safety Study of AMG 228 to Treat Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Data Collection in Patients Undergoing CT-Guided Needle Interventions for NeedleWays System Development
- Status
- UNKNOWN
- Phase
- NA
Ph Ib/BGJ398/Cervix and Other Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Detection of Tumor DNA in Blood Samples From Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Phase 1 Study of E7090 in Subjects With Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
to evaluate188Re-BMEDA-liposome in Patient With Primary Solid Tumor in Advanced or Metastatic Stage
- Status
- TERMINATED
- Phase
- PHASE1
An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2